Comparison of the Effectiveness of the USG and CBCT Combined With Intraoral Scanning Determing the Gingival Phenotype in the Healthy Periodontium
Launched by WROCLAW MEDICAL UNIVERSITY · Apr 13, 2021
Trial Information
Current as of June 19, 2025
Completed
Keywords
ClinConnect Summary
Gingival phenotype (GP) should be determine in each dento-gingival unit as a 3D volume of gingiva with the following parameters: width of keratinized tissue (WKT) and gingival thickness (GT). The phenotype determination is extremely important during many dental procedures, such as in dental surgery, orthodontics, prosthetics or implantology because it allows to dental treatment planning and reduce the risk of complications. Previous methods of determining the gingival phenotype were based on the shape of the crowns of the upper incisors and transparency of the free gingiva. These methods ar...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • lack of general diseases
- • good oral hygiene
- • healthy periodontium - API ratio\<15%, BOP\<10%
- • no loss of clinical attachment in the examined areas (CAL=0)
- • no use of drugs
- • no addictions, especially cigarette smoking
- • no use of mobile prosthetic restorations and orthodontic appliances
- • no contraindications for X-ray examinations
- Exclusion Criteria:
- • general diseases
- • poor oral hygiene
- • non healthy periodontium - API ratio\>15%, BOP\>10%
- • loss of clinical attachment in the examined areas (CAL\>1)
- • use of drugs that could influence the structure of the periodontal tissues
- • addictions, especially nicotinism
- • use of mobile prosthetic restorations and orthodontic appliances
- • contraindications for X-ray examinations
About Wroclaw Medical University
Wrocław Medical University is a prestigious academic institution located in Wrocław, Poland, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in healthcare and biomedical sciences to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical practices and regulatory compliance, Wrocław Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the development of new therapies and enhance the understanding of various medical conditions. Its dedication to scientific excellence and patient safety positions the university as a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wrocław, , Poland
Patients applied
Trial Officials
wojciech bednarz, prof
Study Director
wroclaw medical univeristy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials